What is the diagnosis and management for an adult patient with chest pain and EKG ST elevation in leads V2-V3 suggestive of Acute Coronary Syndrome (ACS)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Ya, Nyeri Dada dengan ST Elevasi 2mm di Lead V2-V3 adalah ACS (STEMI)

Pasien dengan nyeri dada dan ST elevasi 2mm di lead V2-V3 harus segera didiagnosis sebagai STEMI dan memerlukan terapi reperfusi emergensi dalam 120 menit. 1

Kriteria Diagnosis STEMI

Diagnosis STEMI ditegakkan berdasarkan kombinasi:

  • Nyeri dada persisten >20 menit yang tidak membaik dengan nitrogliserin 1
  • ST elevasi pada EKG yang persisten, dengan kriteria:
    • ST elevasi ≥1mm (0.1 mV) di dua lead yang berdekatan (contiguous leads) 1, 2
    • Untuk lead V2-V3 khususnya, ST elevasi 2mm sudah memenuhi kriteria STEMI 1
  • Peningkatan biomarker jantung (troponin T/I atau CK-MB), namun jangan menunggu hasil troponin untuk memulai terapi reperfusi 1

Mengapa Ini Termasuk ACS?

Berdasarkan panduan ESC, pasien dengan nyeri dada akut dibagi menjadi dua kategori berdasarkan EKG 1:

  1. ST-segment elevation ACS (STEMI) - mencerminkan oklusi koroner total/subtotal akut, memerlukan reperfusi segera 1
  2. Non-ST-segment elevation ACS (NSTE-ACS) - tanpa ST elevasi persisten 1

Kasus Anda dengan ST elevasi 2mm di V2-V3 jelas masuk kategori pertama (STEMI). 1

Tatalaksana Emergensi yang Harus Segera Dilakukan

1. Terapi Reperfusi Segera (Target <120 menit)

  • Primary PCI adalah pilihan utama jika dapat dilakukan dalam 120 menit dari kontak medis pertama, menurunkan mortalitas dari 9% menjadi 7% 3, 4
  • Fibrinolitik jika PCI tidak tersedia dalam 120 menit 3, 4:
    • Usia <75 tahun: alteplase, reteplase, atau tenecteplase dosis penuh 3
    • Usia ≥75 tahun: dosis setengah 3
    • Setelah fibrinolitik, transfer untuk PCI dalam 24 jam 3

2. Terapi Medikamentosa Segera

  • Aspirin 75-150 mg segera 1, 4
  • Dual antiplatelet therapy (aspirin + clopidogrel/ticagrelor) 1, 4
  • Antikoagulan parenteral (heparin/LMWH) 1, 4
  • Morfin 4-8 mg IV untuk nyeri, dapat diulang 2 mg tiap 5 menit 1
  • Oksigen 2-4 L/menit hanya jika saturasi <90% atau distres respirasi 5
  • Nitrogliserin IV jika nyeri persisten 1
  • Beta-blocker 1, 4

3. Monitoring Ketat

  • Monitor EKG kontinyu dengan kapabilitas defibrilasi 5
  • Pasang defibrillator patches pada pasien dengan iskemia ongoing 5
  • Vital signs regular 5

Peringatan Penting (Common Pitfalls)

Jangan Menunggu Troponin untuk Memulai Reperfusi

Meskipun troponin diperlukan untuk diagnosis definitif MI, terapi reperfusi harus dimulai segera berdasarkan EKG saja, tanpa menunggu hasil troponin 1. Ini adalah kesalahan fatal yang sering terjadi.

Pertimbangkan Lead Tambahan

  • Lead V7-V9 berguna untuk mendeteksi infark posterior yang mungkin terlewat 1
  • EKG serial harus dilakukan jika EKG awal meragukan atau gejala persisten 1

Waspadai Presentasi Atipikal

Terutama pada:

  • Lansia: sering presentasi dengan fatigue, dyspnea, atau sinkop tanpa nyeri dada tipikal 1
  • Diabetes: dapat presentasi dengan gejala atipikal 5
  • Wanita: lebih sering gejala non-spesifik 5

Namun pada kasus ini dengan ST elevasi 2mm yang jelas di V2-V3, diagnosis STEMI sudah pasti terlepas dari presentasi klinis. 1

Diferensial Diagnosis ST Elevasi Lainnya

Meskipun ST elevasi 2mm di V2-V3 dengan nyeri dada sangat sugestif STEMI, pertimbangkan juga 5:

  • Perikarditis (biasanya ST elevasi difus, bukan terlokalisir)
  • Aneurisma ventrikel kiri (ST elevasi persisten setelah MI lama)
  • Early repolarization (biasanya tanpa nyeri dada)
  • Takotsubo cardiomyopathy

Namun dalam konteks nyeri dada akut, selalu treat as STEMI until proven otherwise. 1

Target Waktu Kritis

  • EKG dalam 10 menit dari kedatangan 1, 5
  • Reperfusi dalam 120 menit dari kontak medis pertama 3, 4
  • Door-to-balloon time <90 menit untuk PCI 3
  • Door-to-needle time <30 menit untuk fibrinolitik 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Acute Coronary Syndrome: Diagnostic Evaluation.

American family physician, 2017

Guideline

ECG Changes in Non-ST-Elevation Myocardial Infarction (NSTEMI)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the treatment for a patient presenting with Acute Coronary Syndrome (ACS), characterized by chest pain and diaphoresis, with electrocardiogram (ECG) findings of ST depression in multiple leads and elevated troponin levels?
What is the diagnostic approach for a patient presenting with chest pain suspected to be of cardiac origin (cardiac)?
What is the initial step to rule out Acute Coronary Syndrome (ACS) in a patient?
What is the best course of action for a patient with a history of myocardial infarction, presenting with intermittent chest and leg pain, nausea, and impaired renal function, while on clopidogrel, dapagliflozin, sitagliptin, atorvastatin, gliglazide, amlodipine, and losartan?
What is the significance of neck pain and palpitations in a patient with a history of cardiovascular disease or risk factors for cardiac disease, and how is it related to acute coronary syndrome?
What is the recommended treatment plan for a patient with bronchial asthma?
How do you test for rigidity in an older adult patient with a history of neurological or musculoskeletal conditions, potentially related to Parkinson's disease or medication side effects?
Is it possible to test for lactose intolerance?
What are the causes of diffuse alveolar hemorrhage, particularly in patients with a history of autoimmune disorders, bleeding disorders, or those taking anticoagulant medications such as warfarin (coumarin) or heparin?
What is the first line treatment for an adult male patient with Benign Prostatic Hyperplasia (BPH) who develops contact dermatitis?
What is the recommended prophylaxis for a patient at risk for Pneumocystis jirovecii pneumonia (PCP), particularly those with HIV/AIDS and a low CD4 count?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.